GlaxoSmithKline announced the initiation of the first study of its kind designed to compare the immunogenicity of its cervical cancer candidate vaccine, CERVARIX?, versus Gardasil?.
Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology at Houston have discovered a toxin present in the bacteria responsible for the current nationwide outbreak of staph infections also has a role in an aggressive pneumonia that is often fatal within 72 hours.
Women with breast cancer who are obese or less educated are twice as likely to get reduced doses of chemotherapy than doctors recommended, jeopardizing survival, according to scientists at the University of Rochester Medical Center.
Women who took more control over choosing their breast cancer surgeon were more likely to be treated by more experienced breast surgeons and at a hospital affiliated with an accredited cancer program, compared to women who were referred by another doctor or their health plan, according to a study led by researchers at the University of Michigan Comprehensive Cancer Center.
In spite of the high use of complementary and alternative medicine (CAM) among people age 50 or older, 69 percent of those who use CAM do not talk to their doctors about it, according to a new survey conducted by AARP and the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health. The survey examined conversations between patients and their physicians regarding CAM use.
A new study concludes that low birthweight babies born with low sodium in their blood serum will likely consume large quantities of dietary sodium later in life. Researchers also found that newborns with the most severe cases of low sodium blood serum consumed ~1700 mg more sodium per day and weighed some 30 percent more than their peers.
Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
Scientists at UCLA and NYU have deciphered the genome of the parasite causing trichomoniasis, and their research may lead to new approaches to improve the diagnosis and treatment of this common sexually transmitted disease. Trichomoniasis affects an estimated 170 million people a year, with more than five million cases reported in North America.
Researchers at Children?s Hospital of Pittsburgh of UPMC have launched a major National Institutes of Health-funded study to develop definitive treatment guidelines for the most common pediatric illness ? ear infections.
Advanced Cell Technology, Inc., applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, has been awarded a research grant from the National Institutes of Health (NIH) in the amount of $204,439 in conjunction with a research project currently underway with one of its academic partners, The Burnham Institute of Medical Research (Burnham Institute).